Leen Thielemans

Corporate Officer/Principal presso Dynacure SA

49 anni

Consumer Services

Health Services

Profilo

Leen Thielemans is currently the Chief Development Officer at Dynacure SA since 2019.
She holds a doctorate degree from Katholieke Universiteit Leuven and a graduate degree from the University of Antwerp.

Posizioni attive di Leen Thielemans

Società	Posizione	Inizio
Dynacure SA Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.	Corporate Officer/Principal	01/02/2019

Tutte le posizioni attive di Leen Thielemans

Formazione di Leen Thielemans

Katholieke Universiteit Leuven	Doctorate Degree
University of Antwerp	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Leen Thielemans

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Dynacure SA Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.	Health Services